Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Journal for Immunotherapy of Cancer|November 24, 2022
Imaging endpoints for clinical trial use: a RECIST perspectiveSaskia Litière, Jan BogaertsAnti-Cancer Drugs|June 29, 2011
Design issues in head and neck clinical trials: a statistician's perspectiveCatherine Fortpied, Cecilia Liberatoscioli, Jan BogaertsJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2013
Designing transformative clinical trials in the cancer genome eraStefan Sleijfer, Jan Bogaerts, Lillian L SiuEuropean Journal of Cancer (Oxford, England : 1990)|October 9, 2017
'Mind the gap' between the development of therapeutic innovations and the clinical practice in oncology: A proposal of the European Organisation for Research and Treatment of Cancer (EORTC) to optimise cancer clinical researchEmmanuelle Kempf, Jan Bogaerts, Denis Lacombe, et al.Current Opinion in Oncology|April 7, 2007
Clinical trial design limitations in head and neck squamous cell carcinomasHwan Jung Yun, Jan Bogaerts, Ahmad Awada, et al.Statistical Methods in Medical Research|April 21, 2017
Surrogate marker analysis in cancer clinical trials through time-to-event mediation techniquesSjouke Vandenberghe, Luc Duchateau, Leen Slaets, et al.Molecular Oncology|October 29, 2014
The dream and reality of histology agnostic cancer clinical trialsDenis Lacombe, Susen Burock, Jan Bogaerts, et al.Nature Reviews. Clinical Oncology|December 21, 2016
RECIST - learning from the past to build the futureSaskia Litière, Sandra Collette, Elisabeth G E de Vries, et al.European Journal of Cancer (Oxford, England : 1990)|December 22, 2023
Attitudes of healthcare professionals and drug regulators about progression-free survival as endpoint in the advanced cancer settingDouwe Postmus, Saskia Litiere, Jan Bogaerts, et al.Molecular Oncology|December 19, 2018
Late translational research: putting forward a new model for developing new anti-cancer treatments that addresses the needs of patients and societyDenis Lacombe, Jan Bogaerts, Bertrand Tombal, et al.Pageof 7